Chapter 1. ROBOTICS FOR RADIOTHERAPY MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. ROBOTICS FOR RADIOTHERAPY MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. ROBOTICS FOR RADIOTHERAPY MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. ROBOTICS FOR RADIOTHERAPY MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. ROBOTICS FOR RADIOTHERAPY MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. ROBOTICS FOR RADIOTHERAPY MARKET – By Type

6.1. Product

6.2. Service

Chapter 7. ROBOTICS FOR RADIOTHERAPY MARKET – By Technology

7.1. External Beam Radiotherapy

       7.1.1. Linear Accelerators

      7.1.1.1. Conventional Linear Accelerators

      7.1.1.2. Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators

        7.1.1.2.1. Gamma Knife

        7.1.1.2.2. CyberKnife

        7.1.1.2.3. TomoTherapy

       7.1.2. Conventional Cobalt-60 Teletherapy Units

       7.1.3. Particle Therapy Systems

      7.1.3.3. Cyclotrons

      7.1.3.4. Synchrotrons

      7.1.3.5. Synchrocyclotron

7.2. Internal Beam Radiotherapy/Brachytherapy

       7.2.1. Seeds

       7.2.2. Afterloaders

       7.2.3. Applicators

       7.2.4. IORT Systems

7.3. Systemic Radiotherapy

       7.3.1. Iobenguane (I-131)

       7.3.2. Samarium-153

       7.3.3. Rhenium-186

       7.3.4. Other Systemic Radiotherapy Products*

Chapter 8. ROBOTICS FOR RADIOTHERAPY MARKET – By Application

8.1. External Beam Radiotherapy

      8.1.1. Prostate Cancer

      8.1.2. Breast Cancer

      8.1.3. Lung Cancer

      8.1.4. Head and Neck Cancer

      8.1.5. Colorectal Cancer

      8.1.6. Other Cancers*

8.2. Internal Beam Radiotherapy/Brachytherapy

       8.2.1. Prostate Cancer

       8.2.2. Gynecological Cancer

       8.2.3. Breast Cancer

       8.2.4. Cervical Cancer

       8.2.5. Penile Cancer

       8.2.6. Other Cancers

       8.2.7. Intensity-modulated Radiotherapy

       8.2.8. Stereotactic Therapy

       8.2.9. Particle Therapy

       8.2.10. 3D Conformal Radiotherapy

8.3. Internal Beam Radiotherapy/Brachytherapy

       8.3.1. High-dose-rate Brachytherapy

       8.3.2. Low-dose-rate Brachytherapy

       8.3.3. Pulsed-dose-rate Brachytherapy

8.4. Systemic Radiotherapy

8.5. Intravenous Radiotherapy

8.6. Oral Radiotherapy

8.7. Instillation Radiotherapy

Chapter 9. ROBOTICS FOR RADIOTHERAPY MARKET – By End User

9.1. Hospitals

9.2. Independent Radiotherapy Centers

Chapter 10. ROBOTICS FOR RADIOTHERAPY MARKET – By Region

10.1. North America

10.2. Europe

10.3.The Asia Pacific

10.4.Latin America

10.5. Middle-East and Africa

Chapter 11. ROBOTICS FOR RADIOTHERAPY MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

11.1. Company 1

11.2. Company 2

11.3. Company 3

11.4. Company 4

11.5. Company 5

11.6. Company 6

11.7. Company 7

11.8. Company 8

11.9. Company 9

11.10. Company 10

Download Sample